Cargando…
Survival benefit of living-donor liver transplantation in patients with a model for end-stage liver disease over 30 in a region with severe organ shortage: a retrospective cohort study
BACKGROUND: The benefits of living-donor liver transplantation (LDLT) in patients with a high Model for End-stage Liver Disease (MELD) score (who have high waitlist mortality) are unclear. Regional availability of deceased-donor organs must be considered when evaluating LDLT benefits. The authors ai...
Autores principales: | Yim, Seung Hyuk, Kim, Deok Gie, Kang, Minyu, Koh, Hwa Hee, Choi, Mun Chae, Min, Eun Ki, Lee, Jae Geun, Kim, Myoung Soo, Joo, Dong Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651284/ https://www.ncbi.nlm.nih.gov/pubmed/37565633 http://dx.doi.org/10.1097/JS9.0000000000000634 |
Ejemplares similares
-
Predicted Impact of the Model for End-Stage Liver Disease 3.0 in a Region Suffering Severe Organ Shortage
por: Kim, Deok-Gie, et al.
Publicado: (2023) -
Risk Factors for Cytomegalovirus Infection and Its Impact on Survival after Living Donor Liver Transplantation in South Korea: A Nested Case-Control Study
por: Yim, Seung Hyuk, et al.
Publicado: (2023) -
Unusual grafts for living-donor liver transplantation
por: Yim, Seung Hyuk, et al.
Publicado: (2023) -
Cumulative exposure to tacrolimus during early period after liver transplantation does not affect the recurrence of hepatocellular carcinoma
por: Kim, Deok-Gie, et al.
Publicado: (2023) -
Antiplatelet Drugs on the Recurrence of Hepatocellular Carcinoma after Liver Transplantation
por: Choi, Mun Chae, et al.
Publicado: (2022)